Shifting landscape of infectious diseases in hematologic malignancies: A hematopoietic cell transplantation and cellular therapy special edition

Gabrielle M Haeusler^{1

2

3

4

5}, Jan Styczynski⁶, Andrea J Zimmer⁷

Affiliations

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
³ The Paediatric Integrated Cancer Service, Victoria State Government, Parkville, Victoria, Australia.
⁴ Infection Diseases Unit, Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
⁵ Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁶ Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
⁷ University of Nebraska College of Medicine, Omaha, Nebraska, USA.

Editorial

Gabrielle M Haeusler et al. Transpl Infect Dis. 2023 Nov.

. 2023 Nov:25 Suppl 1:e14195.

doi: 10.1111/tid.14195. Epub 2023 Nov 21.

Gabrielle M Haeusler^{1

2

3

4

5}, Jan Styczynski⁶, Andrea J Zimmer⁷

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
³ The Paediatric Integrated Cancer Service, Victoria State Government, Parkville, Victoria, Australia.
⁴ Infection Diseases Unit, Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
⁵ Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁶ Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
⁷ University of Nebraska College of Medicine, Omaha, Nebraska, USA.

No abstract available

References

1. Rosenquist R, Bernard E, Erkers T, et al. Novel precision medicine approaches and treatment strategies in hematological malignancies. J Intern Med. 2023;294(4):413-436.
1. Cuvelier GDE, Paulson K, Bow EJ. Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections. Transpl Infect Dis. 2023;e14101. Epub ahead of print.
1. Niederwieser D, Baldomero H, Bazuaye N, et al. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica. 2022;107(5):1045-1053.
1. Makos OL, D'Angelo CR. The shifting roles and toxicities of cellular therapies in B-cell malignancies. Transpl Infect Dis. 2023;e14145. Epub ahead of print.
1. Secondino S, Canino C, Alaimo D, et al. Clinical trials of cellular therapies in solid tumors. Cancers (Basel). 2023;15(14). doi:10.3390/cancers15143667